GlassScriptPhysician profile
Lei Gong
NPI 1497934004
$4,276.19
in general payments reported to CMS, 2019-2025
20 companies · $654 in 2025
The $654 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,210 · 2020: $578 · 2022: $121 · 2023: $242 · 2024: $471 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,367.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,096.56 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $659.49 | 2019-2025 | Wegovy, Ozempic |
| Amgen INC. | $658.30 | 2019-2025 | Repatha |
| Lilly USA, LLC | $653.34 | 2019-2024 | Mounjaro |
| Glaxosmithkline, LLC. | $256.41 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $200.46 | 2019-2020 | |
| Pfizer INC. | $157.57 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $89.98 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.10 | 2019-2020 | |
| Abbvie INC. | $79.06 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $73.29 | 2019 | |
| Corcept Therapeutics | $72.12 | 2019 | |
| Astellas Pharma US INC | $42.48 | 2019 | |
| Sunovion Pharmaceuticals INC. | $34.80 | 2019 | |
| Tandem Diabetes Care, INC. | $24.56 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $23.49 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.19 | 2019 | |
| Amarin Pharma, INC. | $18.95 | 2019 | |
| Mylan Specialty L.P. | $18.16 | 2019 | |
| Shire North American Group INC | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lei Gong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.